Buy Retatrutide — Triple-Agonist Fat Loss Peptide
Retatrutide (LY3437943) is the most potent metabolic peptide available — a triple GLP-1/GIP/GCGR agonist from Eli Lilly that simultaneously targets appetite suppression, insulin sensitivity, and direct fat oxidation.
Buy Retatrutide from QSC
≥99% HPLC purity · Janoshik COA · Free domestic shipping.
Buy Retatrutide at QSC →What Is Retatrutide?
Retatrutide is a novel triple-receptor agonist that simultaneously activates three metabolic receptors: GLP-1R (appetite suppression, gastric emptying), GIPR (insulin sensitivity, glucose metabolism), and GCGR (hepatic fat oxidation, energy expenditure, thermogenesis). The glucagon receptor activation is the key differentiator — it adds a direct fat-burning pathway that single-agonists (semaglutide) and dual-agonists (tirzepatide) lack entirely. Phase 2 clinical trials showed 15–24% mean body weight reduction over 48–72 weeks.
Role in the Venus Protocol
Within the Venus Protocol, Retatrutide provides the potency-optimized metabolic pathway alongside Semaglutide's safety-optimized approach. Combined with the stack's GH axis support (CJC-1295 + Ipamorelin), gut protection (BPC-157), and antioxidant defense (L-Glutathione + NAD+), it enables aggressive body recomposition research without androgens.
Specifications
| Property | Value |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Weight | 4731.33 g/mol |
| Formula | C221H342N46O68 |
| Receptor Targets | GLP-1R, GIPR, GCGR (triple agonist) |
| Purity | ≥99% HPLC |
| Form | Lyophilized powder, 10mg/vial, 10-vial kit |
| Storage | Refrigerated 2–8°C |
The Venus Protocol — 10 Compounds
All 10 compounds from QSC. ≥99% HPLC purity, Janoshik COA, free domestic shipping.
Shop the Venus Protocol at QSC →Venus Protocol
Buy Compounds